POSITION 1: Senior Molecular Diagnostics Scientist, NGS SAGA Diagnostics AB is seeking a talented and highly motivated NGS scientist with strong interest in advancing our mission to revolutionize cancer diagnostics through proprietary ultrasensitive technologies that measure circulating tumor DNA in minimally-invasive “liquid biopsies” such as a simple blood sample. The candidate will work in a […]
Read more Now recruiting 2 job positions: Senior Molecular Diagnostics Scientist NGS + Molecular Diagnostics Scientist dPCR
ABOUT
Precision Cancer Medicine is now. We provide molecular genetic tests and services for healthcare, biopharmaceutical companies, and academia.
Based on leading research from Lund University, Sweden, our proprietary and patent-pending molecular genetic tests are part of a revolution in cancer companion diagnostics and monitoring.
Our tests quantify circulating tumor DNA (ctDNA) — a powerful new biomarker — to detect cancer, measure response to therapy, and decipher the cancer-specific DNA mutations that may be targetable with clinically-approved drugs or therapies currently in clinical trials.
Unique and unprecedented accuracy and sensitivity, with a lower limit of detection that is 10 to 100-fold improved compared to other NGS methods. Our analyses detect what others miss.
The right drug — for the right patient — at the right time.
Our tests quantify circulating tumor DNA (ctDNA) — a powerful new biomarker — to detect cancer, measure response to therapy, and decipher the cancer-specific DNA mutations that may be targetable with clinically-approved drugs or therapies currently in clinical trials.
Unique and unprecedented accuracy and sensitivity, with a lower limit of detection that is 10 to 100-fold improved compared to other NGS methods. Our analyses detect what others miss.
The right drug — for the right patient — at the right time.
